PS24104 - Evaluation of the Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF) and Life Sciences Innovative Manufacturing fund (LSIMF)

Award

Buyers

Value

£0

Suppliers

Classifications

  • Research and development services and related consultancy services

Tags

  • award

Submission Deadline

5 months ago

Published

4 months ago

Description

***** THIS IS AN AWARD NOTICE, NOT A CALL FOR COMPETITION *****

This procurement is being concluded following a mini competition under the CCS RM6126 Research & Insights DPS

Brief Description of Requirement

A formal evaluation of the processes and impacts of MDMTF and LSIMF is required in order to assess achievements against those expected, identify lessons learned to inform future activity. This will evaluate the initial impact of the projects funded in 2020 and 2022 after an initial 3-year timeline. A light touch process evaluation was conducted in 2021 to assess the  programme delivery and early outputs. This resulted in a number of changes to the application process which have been implemented in the delivery of the LSIMF which should also be formally evaluated.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

South Yorkshire Advanced Manufacturing Review

South Yorkshire Mayoral Combined Authority have a requirement for a supplier to support and contribute to a Local Growth Plan which includes analysis of the advanced manufacturing sector in South Yorkshire. Additional information: All tender documents can be found via ProContract. Ref DN752910.

South Yorkshire Mayoral Combined Authority Group

South Yorkshire Mayoral Combined Authority Group

Published 1 day ago
Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

National Institute For Health And Care Excellence

National Institute For Health And Care Excellence

Published 1 day ago
Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

National Institute For Health And Care Excellence

National Institute For Health And Care Excellence

Published 1 day ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

DSIT

Timeline complete

Publish
Bid
Evaluate
Award
Complete